Bioelectronics Corp Stock Market Value

BIEL Stock  USD 0.0003  0.00  0.00%   
Bioelectronics Corp's market value is the price at which a share of Bioelectronics Corp trades on a public exchange. It measures the collective expectations of Bioelectronics Corp investors about its performance. Bioelectronics Corp is selling for 3.0E-4 as of the 15th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Bioelectronics Corp and determine expected loss or profit from investing in Bioelectronics Corp over a given investment horizon. Check out Bioelectronics Corp Correlation, Bioelectronics Corp Volatility and Bioelectronics Corp Alpha and Beta module to complement your research on Bioelectronics Corp.
Symbol

Please note, there is a significant difference between Bioelectronics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioelectronics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioelectronics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bioelectronics Corp 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioelectronics Corp's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioelectronics Corp.
0.00
11/15/2024
No Change 0.00  0.0 
In 30 days
12/15/2024
0.00
If you would invest  0.00  in Bioelectronics Corp on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Bioelectronics Corp or generate 0.0% return on investment in Bioelectronics Corp over 30 days. Bioelectronics Corp is related to or competes with Abbott Laboratories, Stryker, Boston Scientific, Medtronic PLC, Siemens Healthineers, Siemens Healthineers, and Edwards Lifesciences. BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation... More

Bioelectronics Corp Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioelectronics Corp's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioelectronics Corp upside and downside potential and time the market with a certain degree of confidence.

Bioelectronics Corp Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioelectronics Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioelectronics Corp's standard deviation. In reality, there are many statistical measures that can use Bioelectronics Corp historical prices to predict the future Bioelectronics Corp's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioelectronics Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000219.74
Details
Intrinsic
Valuation
LowRealHigh
0.000.000219.74
Details
Naive
Forecast
LowNextHigh
0.0000060.000319.74
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00030.00030.0003
Details

Bioelectronics Corp Backtested Returns

Bioelectronics Corp is out of control given 3 months investment horizon. Bioelectronics Corp secures Sharpe Ratio (or Efficiency) of 0.0909, which signifies that the company had a 0.0909% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.79% are justified by taking the suggested risk. Use Bioelectronics Corp Risk Adjusted Performance of 0.0751, downside deviation of 33.63, and Mean Deviation of 10.68 to evaluate company specific risk that cannot be diversified away. Bioelectronics Corp holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.17, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioelectronics Corp are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioelectronics Corp is expected to outperform it. Use Bioelectronics Corp sortino ratio and the relationship between the potential upside and day median price , to analyze future returns on Bioelectronics Corp.
Correlation Coefficient0.0
Spearman Rank Test0.75
Residual Average0.0
Price Variance0.0

Bioelectronics Corp lagged returns against current returns

Autocorrelation, which is Bioelectronics Corp pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bioelectronics Corp's pink sheet expected returns. We can calculate the autocorrelation of Bioelectronics Corp returns to help us make a trade decision. For example, suppose you find that Bioelectronics Corp has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Bioelectronics Corp regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bioelectronics Corp pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bioelectronics Corp pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bioelectronics Corp pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Bioelectronics Corp Lagged Returns

When evaluating Bioelectronics Corp's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bioelectronics Corp pink sheet have on its future price. Bioelectronics Corp autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bioelectronics Corp autocorrelation shows the relationship between Bioelectronics Corp pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Bioelectronics Corp.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.